CWA
ELV icon

Crux Wealth Advisors’s Elevance Health ELV Stock Holding History

Crux Wealth Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
4,498
-215
-5% -$79.7K 0.6% 48
2026
Q1 		$1.38M Buy
4,713
+158
+3% +$51.9K 0.53% 63
2025
Q4 		$1.6M Sell
4,555
-17
-0.4% -$5.75K 0.59% 51
2025
Q3 		$1.48M Buy
4,572
+484
+12% +$151K 0.59% 51
2025
Q2 		$1.59M Buy
4,088
+1,374
+51% +$553K 0.68% 44
2025
Q1 		$1.18M Buy
2,714
+821
+43% +$330K 0.61% 54
2024
Q4 		$698K Buy
+1,893
New +$792K 0.39% 75

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Crux Wealth Advisors's ELV Position: Q2 2026 in Review

Crux Wealth Advisors reduced its Elevance Health (ELV) stake by 4.6% in Q2 2026, selling an estimated $79.7K and leaving 4,498 shares worth $1.74M. The position accounts for 0.6% of the portfolio, ranked #48.

Crux Wealth Advisors first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Crux Wealth Advisors held 4,498 shares of Elevance Health worth $1.74M as of Q2 2026.
  • Crux Wealth Advisors sold 215 Elevance Health shares in Q2 2026, an estimated $79.7K.
  • Elevance Health made up 0.6% of Crux Wealth Advisors's portfolio in Q2 2026, its #48 holding.
  • Crux Wealth Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Crux Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.